Compare $RGNX vs $SGMT | Chartloom

Compare

$RGNX vs $SGMT

Regenxbio Inc · Sagimet Biosciences Inc

RGNX

Regenxbio Inc

SGMT

Sagimet Biosciences Inc

Compare $RGNX vs $SGMT

Comparing Regenxbio Inc and Sagimet Biosciences Inc

RGNXRegenxbio Inc

SGMTSagimet Biosciences Inc

RGNXRegenxbio Inc

Market cap

$511M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.95x

Rev growth (TTM)

12.0%

YTD performance

-40.5%

52W performance

-34.0%

FCF yield

-48.9%

SGMTSagimet Biosciences Inc

Market cap

$551M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

194.48x

Rev growth (TTM)

—

YTD performance

49.1%

52W performance

22.2%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RGNX

SGMT

Detailed metrics comparison

RGNX

Regenxbio Inc

SGMT

Sagimet Biosciences Inc

Market Cap

RGNX$511M

SGMT$551M

Enterprise Value

RGNX$656M

SGMT$386M

Price

RGNX$8.07

SGMT$8.93

P/E Ratio

RGNXN/A

SGMTN/A

P/S Ratio

RGNX2.93x

SGMT0.00x

EV/Sales

RGNX3.76x

SGMT0.00x

EV/EBITDA

RGNX5.30x

SGMT0.00x

P/B Ratio

RGNX6.83x

SGMT2.20x

P/FCF Ratio

RGNXN/A

SGMTN/A

EV/FCF

RGNX-2.63x

SGMT-9.24x

PEG Ratio

RGNXN/A

SGMTN/A

Forward P/E (NTM)

RGNXN/A

SGMTN/A

Forward P/S (NTM)

RGNX5.95x

SGMT194.48x

Revenue (TTM)

RGNX$174M

SGMT$0

Revenue Growth (YoY)

RGNX12.0%

SGMTN/A

Forward Rev Growth

RGNX25.9%

SGMT89.0%

Gross Margin (TTM)

RGNX86.4%

SGMT0.0%

Operating Margin (TTM)

RGNX0.0%

SGMT0.0%

EBITDA Margin (TTM)

RGNX-85.3%

SGMT0.0%

Net Margin (TTM)

RGNX-112.6%

SGMT0.0%

FCF Margin (TTM)

RGNX-143.1%

SGMTN/A

Net Income (TTM)

RGNX$-196M

SGMT$-47M

FCF (TTM)

RGNX$-250M

SGMT$-42M

EPS (TTM)

RGNX-$3.71

SGMT-$0.89

ROE (TTM)

RGNX-22007.0%

SGMT-3196.0%

ROA (TTM)

RGNX-4604.0%

SGMT-3057.0%

ROIC (TTM)

RGNX-7179.0%

SGMT-3196.0%

Cash

RGNX$36M

SGMT$166M

Debt

RGNX$182M

SGMT$0

Net Cash/Debt

RGNX$-145M

SGMT$166M

Current Ratio (TTM)

RGNX2.86x

SGMT45.02x

Quick Ratio (TTM)

RGNX2.71x

SGMT44.43x

Debt/Equity (TTM)

RGNX2.53x

SGMT0.00x

Debt/Assets (TTM)

RGNX0.0%

SGMT0.0%

Interest Coverage (TTM)

RGNXN/A

SGMTN/A

Net Debt/EBITDA (TTM)

RGNX0.00x

SGMT0.00x

Beta

RGNX1.21

SGMT3.54

52W Performance

RGNX-34.0%

SGMT22.2%

YTD Performance

RGNX-40.5%

SGMT49.1%

% from 52W High

RGNX-50.2%

SGMT-22.0%

% from 52W Low

RGNX47.9%

SGMT98.4%

Asset Turnover (TTM)

RGNX0.41x

SGMT0.00x

FCF Yield (TTM)

RGNX-48.9%

SGMT-7.6%

Earnings Yield (TTM)

RGNX-38.5%

SGMT-8.5%

Dividend Yield (TTM)

RGNXN/A

SGMTN/A

Rule of 40

RGNX-131.1

SGMT0.0

EV/GP/RG

RGNX0.15

SGMTN/A

Ticker research

View RGNX research View SGMT research

Metric	RGNX Regenxbio Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$511M	$551M
Enterprise Value	$656M	$386M
Price	$8.07	$8.93
P/E Ratio	N/A	N/A
P/S Ratio	2.93x	0.00x
EV/Sales	3.76x	0.00x
EV/EBITDA	5.30x	0.00x
P/B Ratio	6.83x	2.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.63x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.95x	194.48x
Revenue & Growth
Revenue (TTM)	$174M	$0
Revenue Growth (YoY)	12.0%	N/A
Forward Rev Growth	25.9%	89.0%
Profitability
Gross Margin (TTM)	86.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-85.3%	0.0%
Net Margin (TTM)	-112.6%	0.0%
FCF Margin (TTM)	-143.1%	N/A
Net Income (TTM)	$-196M	$-47M
FCF (TTM)	$-250M	$-42M
EPS (TTM)	-$3.71	-$0.89
ROE (TTM)	-22007.0%	-3196.0%
ROA (TTM)	-4604.0%	-3057.0%
ROIC (TTM)	-7179.0%	-3196.0%
Financial Health
Cash	$36M	$166M
Debt	$182M	$0
Net Cash/Debt	$-145M	$166M
Current Ratio (TTM)	2.86x	45.02x
Quick Ratio (TTM)	2.71x	44.43x
Debt/Equity (TTM)	2.53x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	3.54
52W Performance	-34.0%	22.2%
YTD Performance	-40.5%	49.1%
% from 52W High	-50.2%	-22.0%
% from 52W Low	47.9%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	0.41x	0.00x
FCF Yield (TTM)	-48.9%	-7.6%
Earnings Yield (TTM)	-38.5%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-131.1	0.0
EV/GP/RG	0.15	N/A
Ticker research	View RGNX research	View SGMT research

Valuation

P/S Ratio

SGMT

0.00x

RGNX

2.93x

EV/FCF

SGMT

-9.24x

RGNX

-2.63x

Growth & revenue

Revenue Growth TTM

RGNX

12.0%

Forward Revenue Growth

SGMT

89.0%

RGNX

25.9%

Profitability & performance

Gross Margin

RGNX

86.4%

SGMT

0.0%

ROE

SGMT

-3196.0%

RGNX

-22007.0%

FCF Yield %

SGMT

-7.6%

RGNX

-48.9%

52-Week Performance

SGMT

22.2%

RGNX

-34.0%

Detailed metrics comparison

RGNX

Regenxbio Inc

SGMT

Sagimet Biosciences Inc

Market Cap

RGNX$511M

SGMT$551M

Enterprise Value

RGNX$656M

SGMT$386M

Price

RGNX$8.07

SGMT$8.93

P/E Ratio

RGNXN/A

SGMTN/A

P/S Ratio

RGNX2.93x

SGMT0.00x

EV/Sales

RGNX3.76x

SGMT0.00x

EV/EBITDA

RGNX5.30x

SGMT0.00x

P/B Ratio

RGNX6.83x

SGMT2.20x

P/FCF Ratio

RGNXN/A

SGMTN/A

EV/FCF

RGNX-2.63x

SGMT-9.24x

PEG Ratio

RGNXN/A

SGMTN/A

Forward P/E (NTM)

RGNXN/A

SGMTN/A

Forward P/S (NTM)

RGNX5.95x

SGMT194.48x

Revenue (TTM)

RGNX$174M

SGMT$0

Revenue Growth (YoY)

RGNX12.0%

SGMTN/A

Forward Rev Growth

RGNX25.9%

SGMT89.0%

Gross Margin (TTM)

RGNX86.4%

SGMT0.0%

Operating Margin (TTM)

RGNX0.0%

SGMT0.0%

EBITDA Margin (TTM)

RGNX-85.3%

SGMT0.0%

Net Margin (TTM)

RGNX-112.6%

SGMT0.0%

FCF Margin (TTM)

RGNX-143.1%

SGMTN/A

Net Income (TTM)

RGNX$-196M

SGMT$-47M

FCF (TTM)

RGNX$-250M

SGMT$-42M

EPS (TTM)

RGNX-$3.71

SGMT-$0.89

ROE (TTM)

RGNX-22007.0%

SGMT-3196.0%

ROA (TTM)

RGNX-4604.0%

SGMT-3057.0%

ROIC (TTM)

RGNX-7179.0%

SGMT-3196.0%

Cash

RGNX$36M

SGMT$166M

Debt

RGNX$182M

SGMT$0

Net Cash/Debt

RGNX$-145M

SGMT$166M

Current Ratio (TTM)

RGNX2.86x

SGMT45.02x

Quick Ratio (TTM)

RGNX2.71x

SGMT44.43x

Debt/Equity (TTM)

RGNX2.53x

SGMT0.00x

Debt/Assets (TTM)

RGNX0.0%

SGMT0.0%

Interest Coverage (TTM)

RGNXN/A

SGMTN/A

Net Debt/EBITDA (TTM)

RGNX0.00x

SGMT0.00x

Beta

RGNX1.21

SGMT3.54

52W Performance

RGNX-34.0%

SGMT22.2%

YTD Performance

RGNX-40.5%

SGMT49.1%

% from 52W High

RGNX-50.2%

SGMT-22.0%

% from 52W Low

RGNX47.9%

SGMT98.4%

Asset Turnover (TTM)

RGNX0.41x

SGMT0.00x

FCF Yield (TTM)

RGNX-48.9%

SGMT-7.6%

Earnings Yield (TTM)

RGNX-38.5%

SGMT-8.5%

Dividend Yield (TTM)

RGNXN/A

SGMTN/A

Rule of 40

RGNX-131.1

SGMT0.0

EV/GP/RG

RGNX0.15

SGMTN/A

Ticker research

View RGNX research View SGMT research

Metric	RGNX Regenxbio Inc	SGMT Sagimet Biosciences Inc
Market & Valuation
Market Cap	$511M	$551M
Enterprise Value	$656M	$386M
Price	$8.07	$8.93
P/E Ratio	N/A	N/A
P/S Ratio	2.93x	0.00x
EV/Sales	3.76x	0.00x
EV/EBITDA	5.30x	0.00x
P/B Ratio	6.83x	2.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.63x	-9.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.95x	194.48x
Revenue & Growth
Revenue (TTM)	$174M	$0
Revenue Growth (YoY)	12.0%	N/A
Forward Rev Growth	25.9%	89.0%
Profitability
Gross Margin (TTM)	86.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-85.3%	0.0%
Net Margin (TTM)	-112.6%	0.0%
FCF Margin (TTM)	-143.1%	N/A
Net Income (TTM)	$-196M	$-47M
FCF (TTM)	$-250M	$-42M
EPS (TTM)	-$3.71	-$0.89
ROE (TTM)	-22007.0%	-3196.0%
ROA (TTM)	-4604.0%	-3057.0%
ROIC (TTM)	-7179.0%	-3196.0%
Financial Health
Cash	$36M	$166M
Debt	$182M	$0
Net Cash/Debt	$-145M	$166M
Current Ratio (TTM)	2.86x	45.02x
Quick Ratio (TTM)	2.71x	44.43x
Debt/Equity (TTM)	2.53x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	3.54
52W Performance	-34.0%	22.2%
YTD Performance	-40.5%	49.1%
% from 52W High	-50.2%	-22.0%
% from 52W Low	47.9%	98.4%
Efficiency & Yields
Asset Turnover (TTM)	0.41x	0.00x
FCF Yield (TTM)	-48.9%	-7.6%
Earnings Yield (TTM)	-38.5%	-8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-131.1	0.0
EV/GP/RG	0.15	N/A
Ticker research	View RGNX research	View SGMT research